NTAP vs PASG · P/E 28, rev $6.57B vs $25.2M cap
NetApp Inc (NTAP) versus Passage Bio Inc (PASG) — a side-by-side from cached financials, not a winner call.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Passage Bio Inc (PASG) is a biotechnology company listed on US.
Latest reported NTAP revenue for 2025-04-25 was $6.57B. Net income was $1.19B. Revenue was up 4.9% from 2024-04-26 to 2025-04-25. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
PASG does not have a complete income-statement cache yet.
NTAP currently screens at market cap $35.43B and trailing P/E 28.2. PASG currently screens at market cap $25.2M.
Not investment advice. Open the NTAP and PASG stock pages for the full models.
Not investment advice.